Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595235 | SCV000709628 | likely benign | not specified | 2017-06-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001143372 | SCV001303893 | uncertain significance | Sitosterolemia 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Labcorp Genetics |
RCV001521409 | SCV001730749 | benign | Sitosterolemia | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584407 | SCV001812304 | likely benign | not provided | 2020-07-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24503134) |
Genetic Services Laboratory, |
RCV000595235 | SCV002070903 | likely benign | not specified | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404614 | SCV002707232 | benign | Cardiovascular phenotype | 2019-07-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001584407 | SCV004146001 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | ABCG5: BP4, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000595235 | SCV005185385 | uncertain significance | not specified | 2024-05-07 | criteria provided, single submitter | clinical testing | Variant summary: ABCG5 c.1567A>G (p.Ile523Val) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0019 in 1614184 control chromosomes in the gnomAD database, including 10 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in ABCG5 causing Early Onset Coronary Artery Disease (0.0019 vs 0.005), allowing no conclusion about variant significance. c.1567A>G has been reported in the literaturein at-least one patient suspected of partial lipodystrophy without strong evidence for causality (example: Johansen_2014). These report(s) do not provide unequivocal conclusions about association of the variant with Early Onset Coronary Artery Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24503134, 32088153). ClinVar contains an entry for this variant (Variation ID: 502765). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. |
Genome Diagnostics Laboratory, |
RCV001584407 | SCV001931328 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000595235 | SCV001978780 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003915740 | SCV004729677 | likely benign | ABCG5-related disorder | 2019-05-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |